What amount sold does ZEVEZ PAYMENTS, INC. report in Form D filings?

The latest linked filings report $22M sold across 10 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was ZEVEZ PAYMENTS, INC.'s most recent SEC filing?

ZEVEZ PAYMENTS, INC.'s most recent Form D filing was on 2018-11-01.

How many investors does ZEVEZ PAYMENTS, INC. have?

The most recent Form D filing lists 4 investor(s).

What type of securities does ZEVEZ PAYMENTS, INC. offer?

ZEVEZ PAYMENTS, INC.'s SEC Form D filings indicate equity, debt offerings.

ZEVEZ PAYMENTS, INC.

CIK: 0001467867·Other Technology·BEAVERTON, OR·Corporation

Reported Sold

$22,036,976

Total Filings

Identified Offerings

Last Filed

Nov 1, 2018

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Technology industry

SEC EDGAR

Offering filing timeline

Nov 1, 2018Form D — New notice

Reported sold: $3,500,000 · Target: $5,000,000

Rule 506(b)·4 investors

Oct 21, 2016Form D — New notice

Reported sold: $10,000,000 · Target: $10,700,000

Rule 506(b)·1 investor

Feb 5, 2016Form D — New notice

Reported sold: $0 · Target: $10,000,000

Rule 506(b)·0 investors

Aug 17, 2015Form D — New notice

Reported sold: $1,835,000 · Target: $25,000,000

Rule 506(b)·5 investors

Apr 13, 2015Form D/A — Amendment

Reported sold: $3,045,516 · Target: $5,000,000

Rule 506(b)·8 investors

Changed: Reported amount sold, Offering target, Reported investors

Jun 5, 2014Form D — New notice

Reported sold: $1,250,003 · Target: $1,500,000

Rule 506(b)·2 investors

Jul 18, 2013Form D — New notice

Reported sold: $100,000 · Target: $1,000,000

Rule 506·1 investor

Dec 20, 2012Form D/A — Amendment

Reported sold: $2,366,432 · Target: $2,500,000

Rule 506·25 investors

Changed: Reported amount sold, Offering target, Reported investors

Aug 31, 2012Form D/A — Amendment

Reported sold: $1,953,038 · Target: $2,000,000

Rule 506·22 investors

Changed: Reported amount sold, Offering target, Reported investors, Exemptions

Dec 29, 2010Form D/A — Amendment

Reported sold: $500,000 · Target: $500,000

Rule 506·7 investors·Section 4(6)

Changed: Reported amount sold, Reported investors

Dec 29, 2010Form D — New notice

Reported sold: $270,000 · Target: $1,250,000

Rule 506·3 investors·Section 4(6)

Oct 25, 2010Form D — New notice

Reported sold: $225,000 · Target: $500,000

Rule 506·4 investors·Section 4(6)

Apr 12, 2010Form D/A — Amendment

Reported sold: $540,028 · Target: $540,031

Rule 506·11 investors·Section 4(6)

Changed: Reported amount sold, Offering target, Reported investors

Jan 13, 2010Form D — New notice

Reported sold: $90,030 · Target: $500,000

Rule 506·4 investors·Section 4(6)

Dec 14, 2009Form D/A — Amendment

Reported sold: $150,000 · Target: $500,000

Rule 506·4 investors·Section 4(6)

Changed: Reported amount sold, Reported investors

Aug 5, 2009Form D — New notice

Reported sold: $100,000 · Target: $500,000

Rule 506·2 investors·Section 4(6)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

38%

Latest reported sold across 10 identified offerings

$22,036,976

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

David Chen

Related Person

Appears on 7 filings

Karla Friede

Related Person

Appears on 7 filings

Garen K. Staglin

Related Person

Appears on 5 filings

E. Miles Kilburn

Related Person

Appears on 5 filings

Garen K. Staglin

Related Person

Appears on 5 filings

Karla Friede

Related Person

Appears on 5 filings

David Chen

Related Person

Appears on 4 filings

E. Miles Kilburn

Related Person

Appears on 4 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Nov 1, 2018	New	$5,000,000	$3,500,000	4
Oct 21, 2016	New	$10,700,000	$10,000,000	1
Feb 5, 2016	New	$10,000,000	$0	0
Aug 17, 2015	New	$25,000,000	$1,835,000	5
Apr 13, 2015	Amendment	$5,000,000	$3,045,516	8
Jun 5, 2014	New	$1,500,000	$1,250,003	2
Jul 18, 2013	New	$1,000,000	$100,000	1
Dec 20, 2012	Amendment	$2,500,000	$2,366,432	25
Aug 31, 2012	Amendment	$2,000,000	$1,953,038	22
Dec 29, 2010	New	$1,250,000	$270,000	3
Dec 29, 2010	Amendment	$500,000	$500,000	7
Oct 25, 2010	New	$500,000	$225,000	4
Apr 12, 2010	Amendment	$540,031	$540,028	11
Jan 13, 2010	New	$500,000	$90,030	4
Dec 14, 2009	Amendment	$500,000	$150,000	4
Aug 5, 2009	New	$500,000	$100,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Araceli Biosciences Inc.

Other Technology

Offering target: $4,500,000

Filed Nov 3, 2026